Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bridged diazepane orexin receptor antagonists

Bridged diazepane orexin receptor antagonists

US Patent 9994570 · Granted Jun 12, 2018

Estimated economic value: $89,973,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tetrahydroquinazoline derivatives as selective cytotoxic agents2025
Hydroxypyrrolidine-substituted arylsulfonamide compounds with selective activity2025
Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors2025
5-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitors2025
6-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitors2025
Substituted aminopyridine compounds as EGFR inhibitors2024
Substituted aminopyridine compounds as EGFR inhibitors2024
Dihydroorotate dehydrogenase inhibitors2023
Dihydroorotate dehydrogenase inhibitors2022
Oxadiazepinone derivatives and methods of treating hepatitis B infections2021
Diazepinone derivatives and their use in the treatment of hepatitis B infections2021
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in v2021